iNtRON Biotechnology, Inc. (KOSDAQ:048530)
4,625.00
-55.00 (-1.18%)
Mar 12, 2026, 3:30 PM KST
14.76% (1Y)
| Market Cap | 143.46B -15.4% |
| Revenue (ttm) | 5.56B -35.5% |
| Net Income | -6.29B |
| EPS | -197.47 |
| Shares Out | 30.65M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 100.00 (2.14%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 1,868,214 |
| Average Volume | 3,194,235 |
| Open | 4,790.00 |
| Previous Close | 4,680.00 |
| Day's Range | 4,495.00 - 5,130.00 |
| 52-Week Range | 2,895.00 - 7,010.00 |
| Beta | 0.30 |
| RSI | 51.24 |
| Earnings Date | Mar 13, 2026 |